People with operable diffuse pleural mesothelioma may benefit from immunotherapy before and after surgery, based on results ...
People love to joke about not even being able to go to the toilet without bringing a phone with you these days, but it turns out your bathroom scrolling habit may be doing more harm than you think. A ...
Mayo Clinic researchers have identified how excessive alcohol use can drive the development of fatty liver disease. The culprit is a disruption of a protein-recycling enzyme (VCP), which normally ...
Credit: Deutsches Zentrum für Luft- und Raumfahrt e.V. When non-carbon dioxide non-CO 2 effects such as contrails are taken into consideration, the maximum lifecycle reduction in emissions possible ...
Several studies have shown that students who attend afternoon classes tend to perform better in school than those who attend morning classes. This is due to greater synchrony between class times and ...
Nearly 90% of respondents to a study on two college campuses said they'd pretended to be more progressive than they really were to increase their odds of social or academic success. Researchers Forest ...
Our country is poised to take health coverage away from millions of low-income Americans largely based on the findings of a flawed and flagrantly misleading study. President Trump’s budget ...
Reading for pleasure in the U.S. fell 40% over two decades, the study found. Fewer Americans are opening a book for fun each day, with reading for pleasure in the United States down 40% over the past ...
US companies have invested between $35 billion and $40 billion in generative AI (genAI) projects, but most efforts are stuck in the pilot stage, according to a report from MIT’s NANDA initiative. Only ...
Buyers looking for a used car will naturally want to get the best deal they can, but there are many factors that can contribute to how likely they are to score a bargain. Alongside avoiding common car ...
Approximately one-third of patients with relapsed or refractory mantle cell lymphoma (MCL) in this study treated with CAR T-cell therapy experienced disease progression, with a median progression time ...